
AI Coverage
about 9 hours ago
Advances in AI — August 2026Latest News

Advances in AI — August 2026

Misfortune, Mistake, or Malfeasance? A Tool to Hone Outside of Radiology

Diagnostic Imaging’s Weekly Scan: August 16 — August 22

Radiology Roundup of FDA News: August 16 — August 22

From Complexity to Confidence: Reducing Cognitive Load in Modern CT Imaging

Shorts










Podcasts
Videos
Continuing Medical Education
All News

Reducing false positives in evaluation of muscle invasion in bladder cancer cases that can occur with conventional imaging, spectral information with photon-counting CT may offer significantly improved accuracy and specificity in local staging.

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the appeal of the specialty, key advances in the field in recent years, and the need for increased awareness of what interventional radiology can offer to patients.

The AI-powered software NeuroQuant PET reportedly offers automated quantification and structured reporting and facilitates evaluation of brain scans with multiple amyloid PET radiotracers.

Preliminary research with the PET radiopharmaceutical 68Ga-NYM096 has demonstrated a 95.7 percent accuracy rate in patients with primary clear cell renal cell carcinoma (ccRCC) and a significantly higher mean SUVmax in the most active lesions in comparison to 18F-FDG.

For patients who had successful reperfusion after acute ischemic stroke, new research demonstrated an 80 percent AUC for predicting infarct with the combination of apparent diffusion coefficient (ADC) mapping and relative oxygen ejection fraction (rOEF).

In a recent Practice Academy webinar session, Nina Kottler, MD, MS, FSIIM, FAIM, discussed challenges with narrow AI applications, the continued emergence of foundation models and a potential trajectory with AI that may facilitate a combination of opportunistic screening and prognostic risk assessment.

In a recent Practice Academy webinar session, Seena Dehkharghani, MD, FAHA, and Raza Mushtaq, MD, discussed the challenge of burgeoning worklist volume amid the ongoing radiologist shortage and the emergence of AI advances with enterprise imaging.

The cmAngio 2.0 AI-enabled software reportedly offers new capabilities for quantitative measurement of breast arterial calcification (BAC) as well as age-based contextualization based on mammography assessment.

New research revealed that risk-stratified MRI surveillance in patients with cirrhosis led to over a 10 percent increase in early detection and over a 44 percent decrease in surveillance exams in comparison to reported results with semiannual ultrasound monitoring.

While maintenance of certification requires participation in peer review, a collegial ethos enables us to provide assessment of another radiologist’s work without crossing the line into odious expert witness cash grabs.

Catch up on the latest contrast-enhanced mammography research, CT insights, MRI studies and FDA approvals in PET imaging with our Weekly Scan.

Recent positron emission tomography (PET) studies with florquinitau F 18 injection (Tauklarify) demonstrated inter-reader agreement ranging between 86 to 92 percent in evaluating patients for Alzheimer’s disease.

The high-resolution temporal and spatial imaging with photon-counting CT bolster our understanding of the connections between anatomy and function in structural heart imaging.

Use of the CARE Multi-Triage CT Body software will be eligible for a New Technology Add-on Payment (NTAP) from CMS starting on October 1, 2026 for inpatients in Medicare fee for service plans.

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offers her perspective on a new study that examines the effectiveness of contrast-enhanced mammography in initial and subsequent rounds of breast cancer screening.


























